DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,540,019 | +1.6% | 6,207 | -1.7% | 0.02% | +5.6% |
| Q2 2023 | $1,516,140 | -94.0% | 6,317 | -93.7% | 0.02% | -94.1% |
| Q1 2023 | $25,090,393 | -41.8% | 99,549 | -38.7% | 0.31% | -42.4% |
| Q4 2022 | $43,119,169 | -27.3% | 162,456 | -29.2% | 0.53% | -28.1% |
| Q3 2022 | $59,285,000 | +22.2% | 229,530 | +20.0% | 0.74% | +35.2% |
| Q2 2022 | $48,504,000 | -15.2% | 191,322 | -1.9% | 0.55% | -3.0% |
| Q1 2022 | $57,227,000 | -10.7% | 195,093 | +0.2% | 0.56% | -7.5% |
| Q4 2021 | $64,056,000 | +419.6% | 194,694 | +380.8% | 0.61% | +373.6% |
| Q3 2021 | $12,328,000 | +13.3% | 40,495 | -0.1% | 0.13% | +15.2% |
| Q2 2021 | $10,879,000 | +73.0% | 40,538 | +45.1% | 0.11% | +64.7% |
| Q1 2021 | $6,290,000 | +1.7% | 27,947 | +0.4% | 0.07% | 0.0% |
| Q4 2020 | $6,183,000 | +408.1% | 27,832 | +392.6% | 0.07% | +385.7% |
| Q3 2020 | $1,217,000 | +22.9% | 5,650 | +1.0% | 0.01% | +16.7% |
| Q2 2020 | $990,000 | +2.8% | 5,596 | -19.6% | 0.01% | 0.0% |
| Q1 2020 | $963,000 | -3.0% | 6,960 | +7.6% | 0.01% | +20.0% |
| Q4 2019 | $993,000 | +8.5% | 6,470 | +2.1% | 0.01% | +11.1% |
| Q3 2019 | $915,000 | -73.3% | 6,338 | -73.6% | 0.01% | -71.0% |
| Q2 2019 | $3,429,000 | +4.7% | 23,989 | -3.3% | 0.03% | +6.9% |
| Q1 2019 | $3,274,000 | +21.4% | 24,797 | -5.2% | 0.03% | +11.5% |
| Q4 2018 | $2,697,000 | -5.9% | 26,157 | -0.9% | 0.03% | +8.3% |
| Q3 2018 | $2,867,000 | +8.7% | 26,388 | -1.2% | 0.02% | +4.3% |
| Q2 2018 | $2,637,000 | -10.2% | 26,718 | -10.9% | 0.02% | -11.5% |
| Q1 2018 | $2,935,000 | -2.1% | 29,975 | -7.2% | 0.03% | +4.0% |
| Q4 2017 | $2,999,000 | -3.0% | 32,305 | -10.4% | 0.02% | -7.4% |
| Q3 2017 | $3,092,000 | -1.3% | 36,051 | -2.9% | 0.03% | -3.6% |
| Q2 2017 | $3,132,000 | -2.1% | 37,109 | -0.8% | 0.03% | -3.4% |
| Q1 2017 | $3,198,000 | -0.5% | 37,390 | -9.4% | 0.03% | -3.3% |
| Q4 2016 | $3,213,000 | -0.4% | 41,275 | +0.3% | 0.03% | +3.4% |
| Q3 2016 | $3,226,000 | -22.9% | 41,148 | -0.7% | 0.03% | -19.4% |
| Q2 2016 | $4,185,000 | +5.1% | 41,432 | -1.3% | 0.04% | +2.9% |
| Q1 2016 | $3,981,000 | -31.4% | 41,965 | -32.9% | 0.04% | -28.6% |
| Q4 2015 | $5,806,000 | +7.0% | 62,515 | -1.8% | 0.05% | +2.1% |
| Q3 2015 | $5,424,000 | -7.9% | 63,657 | -7.5% | 0.05% | -2.0% |
| Q2 2015 | $5,891,000 | -1.1% | 68,830 | -1.9% | 0.05% | 0.0% |
| Q1 2015 | $5,956,000 | -1.1% | 70,159 | -0.1% | 0.05% | -2.0% |
| Q4 2014 | $6,022,000 | -7.3% | 70,259 | -17.8% | 0.05% | -2.0% |
| Q3 2014 | $6,496,000 | -2.2% | 85,496 | +1.4% | 0.05% | -1.9% |
| Q2 2014 | $6,639,000 | +18.7% | 84,323 | +13.1% | 0.05% | +15.6% |
| Q1 2014 | $5,591,000 | -5.5% | 74,553 | -2.7% | 0.04% | -4.3% |
| Q4 2013 | $5,914,000 | +12.0% | 76,602 | +0.6% | 0.05% | +4.4% |
| Q3 2013 | $5,279,000 | +17.2% | 76,152 | +7.0% | 0.04% | +15.4% |
| Q2 2013 | $4,504,000 | – | 71,161 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |